Intellectual Property

  • March 31, 2025

    Ex-Blood Bank Atty Goes Back To Ballard Spahr In Phoenix

    Ballard Spahr LLP has picked up a former in-house intellectual property lawyer from nonprofit blood bank Vitalant who had worked at the law firm a little over a decade ago.

  • March 31, 2025

    Samsung Bid To Beat Back $192M Patent Award Falls Short

    Texas U.S. District Judge Rodney Gilstrap unsealed a ruling Friday explaining why he decided that a small Silicon Valley outfit's use of continuations in filing wireless charger patents were not unreasonable delays that made the patents unenforceable or void a $192 million verdict against Samsung.

  • March 31, 2025

    Salesforce Gets Judge To Ax Patent Suit Fed. Circ. Revived

    A Nevada federal judge has thrown out a suit accusing Salesforce of infringing patents for database software reprogramming, saying the transfer of the patent rights to the consulting company that sued was voided by an earlier transfer.

  • March 31, 2025

    Intellectual Ventures Urges PTAB To Deny Tesla IP Challenge

    Intellectual Ventures II LLC wants the Patent Trial and Appeal Board to reject Tesla's bid to have the board examine a digital camera patent, pointing to a recent memo from the acting director of the U.S. Patent and Trademark Office saying she and other board judges will review petitions to determine whether they should be denied for discretionary reasons.

  • March 31, 2025

    Fed. Circ. Tells PTAB To Look At Samsung Foe's Patents Again

    Samsung convinced the Federal Circuit Monday that administrative patent board judges used an "erroneous" definition of a term used in two gesture-sensing interface patents that the smartphone giant is accused of infringing in litigation in Texas.

  • March 31, 2025

    Firm Says Ex-Fin. Adviser Can't Arbitrate Trade Secrets Claims

    A Connecticut financial firm told a state court that an ex-adviser can't arbitrate claims that he swiped trade secrets and formed his own competing company, citing the "plain language" of his employment agreement.

  • March 31, 2025

    Nut Butter Co. Says Calif. Rival Copied 'Big Spoon' Trademark

    A North Carolina company that makes various nut butters under the name "Big Spoon" is suing a California sauce company for trademark infringement, saying in a federal complaint that the rival business is selling similar products using the same name and confusing customers.

  • March 31, 2025

    South Dakota Moves To Halt NCAA NIL Settlement Rollout

    South Dakota asked a state court on Monday to stop the NCAA from putting in place a $2.78 billion settlement with athletes in their class action over name, image and likeness compensation, one week before a scheduled hearing for final approval in California federal court.

  • March 31, 2025

    USPTO Cuts Not A Source Of Savings For Trump, Attys Say

    As the Trump administration focuses on shrinking the federal government and reducing agency headcount, the U.S. Patent and Trademark Office should be spared from layoffs and other disruptions because it's fully funded by user fees, attorneys told Law360.

  • March 31, 2025

    USPTO Director Stops 4 Motorola IP Reviews At PTAB

    The acting director of the U.S. Patent and Trademark Office has decided that the Patent Trial and Appeal Board will not review Motorola's challenges to a series of Stellar Inc. patents on glasses equipped with cameras, undoing PTAB decisions instituting the reviews.

  • March 31, 2025

    Colo. Firm Says Former Atty Uses Google Ads To Steal Clients

    A prominent Colorado personal injury law firm has sued a former employee for trademark infringement, accusing the lawyer of purchasing Google ads so prospective clients searching for the Franklin D. Azar & Associates firm are directed to a phone number and website for his lesser-known law firm instead.

  • March 31, 2025

    Carlton Fields Faces DQ Bid In $500M Miss America Suit

    Carlton Fields faces a disqualification bid for allegedly having a conflict of interest in a $500 million lawsuit regarding the ownership of the company that runs the Miss America pageant.

  • March 31, 2025

    Lions Cut Loose From Copyright Row Over Sanders Statue

    Citing jurisdictional grounds, a New York judge has dismissed the Detroit Lions from a lawsuit accusing it and others of improperly using a copyrighted photo to create a statue of legendary running back Barry Sanders, making the team the latest defendant to exit the suit.

  • March 31, 2025

    Faegre Drinker Fights Sanctions Bid In Trump IP Song Suit

    Conservative group Turning Point Action Inc. is urging a Georgia federal judge not to sanction its Faegre Drinker Biddle & Reath LLP counsel in a copyright suit filed by the estate of soul artist Isaac Lee Hayes Jr. over President Donald Trump playing his song "Hold On, I'm Comin'," disputing claims they submitted a "frivolous" dismissal bid.

  • March 31, 2025

    Perkins Coie DQ'd From Facial Recognition IP Suit

    Perkins Coie LLP has been disqualified from defending Jumio Corp. in a patent infringement lawsuit involving facial recognition technology, with the San Francisco federal judge who signed the order citing the firm's prior general corporate and intellectual property representation of plaintiff FaceTec Inc.

  • March 31, 2025

    Nokia, Amazon End Long-Running Patent Feud With License

    Nokia said Monday that it has inked a patent agreement with Amazon to cover its video technology, marking the end of litigation between the two companies across several continents.

  • March 31, 2025

    Cleary Gains 5-Atty Latham Team Known For Big IP Wins

    Cleary Gottlieb Steen & Hamilton LLP has welcomed a bi-coastal team of five intellectual property litigators from Latham & Watkins LLP, lauding their history leading "many of the most high-profile and complex patent and trade secrets cases of the last decade" in a statement Monday.

  • March 28, 2025

    Colo. Beats Amgen's Drug Price Cap Challenge, For Now

    A Colorado federal judge Friday threw out Amgen's challenge to the Centennial State's drug price cap system, finding that Amgen is not subject to "direct regulation" under the law it's challenging and therefore doesn't have standing to sue.

  • March 28, 2025

    Doctor's Counterclaims Cut In 'Groq' TM Feud With Chipmaker

    A Manhattan federal judge says her court can't order the U.S. Patent and Trademark Office to reject pending trademark applications, turning down counterclaims in a fight between generative artificial intelligence inference chipmaker Groq and a notable New York endocrinologist who changed the name of her company to "Groq Health."

  • March 28, 2025

    Duke's 'White Lotus' Cameo Not Likely An IP Problem For HBO

    Duke University officials have spoken out against an HBO show's depiction of a main character in Duke apparel while experiencing a mental health crisis, but intellectual property attorneys say the network is likely well within its rights to use the university's images in its artistic expression. Disclaimer: This story includes spoilers from the show's third season.

  • March 28, 2025

    Ad Display Cos. Bury Hatchet In Arizona Patent Case

    Two ad tech companies say they have reached a deal to end a lawsuit in Arizona federal court over alleged infringement of a patent covering a purportedly novel way of loading advertisements on websites.

  • March 28, 2025

    Dr. Martens Maker Moves To Keep Shein TM Fight Alive

    The maker of Dr. Martens shoes said an affiliate of fast-fashion giant Shein shouldn't be able to dodge accusations of selling knockoff products and violating the terms of a previous intellectual property settlement agreement, arguing it has sufficiently laid out its case.

  • March 28, 2025

    Anthropic Says Using Books For AI Is 'Quintessential' Fair Use

    Anthropic on Thursday moved to toss a group of journalists and authors' proposed class action accusing the artificial intelligence startup of exploiting their copyrighted work to train its large language model, Claude, telling a California federal court that its use of their works was transformative and thus "quintessential fair use."

  • March 28, 2025

    Failed Software Secrets Case Costs MasterCard Unit $2.8M

    A federal judge in Utah has ordered a MasterCard unit to cough up over $2.8 million in legal fees for "aggressively" litigating an "objectively specious" trade secrets suit against two McKinsey consultants who went on to found one of MasterCard's only serious rivals in a corner of the business analytics software market.

  • March 28, 2025

    AIG Trade Secrets Row With Insurance Startup Gets Trimmed

    A New Jersey federal court narrowed a trade secrets theft suit brought by AIG units against a new insurer founded by former senior executives, calling claims of interference with contract, breach of fiduciary duty and unauthorized access of AIG's computers unsupported Friday.

Expert Analysis

  • 4 Do's And Don'ts For Trial Lawyers Using Generative AI

    Author Photo

    Trial attorneys who use artificial intelligence tools should review a few key reminders, from the likelihood that prompts are discoverable to the rapid evolution of court rules, to safeguard against embarrassing missteps, says Nate Sabri at Perkins Coie.

  • Defense Strategies For Politically Charged Prosecutions

    Author Photo

    Politically charged prosecutions have captured the headlines in recent years, providing lessons for defense counsel on how to navigate the distinct challenges, and seize the unique opportunities, such cases present, says Kenneth Notter at MoloLamken.

  • Series

    Competitive Weightlifting Makes Me A Better Lawyer

    Author Photo

    The parallels between the core principles required for competitive weightlifting and practicing law have helped me to excel in both endeavors, with each holding important lessons about discipline, dedication, drive and failure, says Damien Bielli at VF Law.

  • 3 Potential Developments That May Alter US Patent Rights

    Author Photo

    The Federal Circuit's upcoming decision in EcoFactor v. Google, pending legislation before Congress and the appointment of a new U.S Patent and Trademark Office director all have significant potential to strengthen or weaken patent rights, say attorneys at McKool Smith.

  • Opinion

    Inconsistent Injury-In-Fact Rules Hinder Federal Practice

    Author Photo

    A recent Third Circuit decision, contradicting a previous ruling about whether consumers of contaminated products have suffered an injury in fact, illustrates the deep confusion this U.S. Supreme Court standard creates among federal judges and practitioners, who deserve a simpler method of determining which cases have federal standing, says Eric Dwoskin at Dwoskin Wasdin.

  • Takeaways From Oral Argument In High Court Trademark Case

    Author Photo

    Unpacking oral arguments from Dewberry Group v. Dewberry Engineers, which the U.S. Supreme Court is expected to rule on this year, sheds light on the ways in which the decision could significantly affect trademark infringement plaintiffs' ability to receive monetary damages, say attorneys at Buchanan Ingersoll.

  • In-House Counsel Pointers For Preserving Atty-Client Privilege

    Author Photo

    Several recent rulings illustrate the challenges in-house counsel can face when attempting to preserve attorney-client privilege, but a few best practices can help safeguard communications and effectively assert the privilege in an increasingly scrutinized corporate environment, says Daniel Garrie at Law & Forensics.

  • Improving Comms Between Trial Attys And Tech Witnesses

    Author Photo

    In major litigation involving complex technology, attorneys should employ certain strategies to collaborate with companies' technical personnel more effectively to enhance both the attorney's understanding of the subject matter and the expert's ability to provide effective testimony in court, say attorneys at Buchalter.

  • Navigating Title IX Compliance In The NIL Era

    Author Photo

    As universities push to move more name, image and likeness activity in-house, it's unclear how the NCAA and its members will square implementation of the House settlement with Title IX requirements, say attorneys at Buchanan Ingersoll.

  • Series

    Collecting Rare Books Makes Me A Better Lawyer

    Author Photo

    My collection of rare books includes several written or owned by prominent lawyers from early U.S. history, and immersing myself in their stories helps me feel a deeper connection to my legal practice and its purpose, says Douglas Brown at Manatt Health.

  • DeepSeek AI Investigation Could Lead To IP Law Precedents

    Author Photo

    The investigation by OpenAI and Microsoft into DeepSeek's artificial intelligence model raises interesting legal concerns involving intellectual property and contract law, including potential trade secret appropriation and fair use questions, say Saishruti Mutneja and Raghav Gurbaxani.

  • Opinion

    New DOJ Leaders Should Curb Ill-Conceived Prosecutions

    Author Photo

    First-of-their-kind cases have seemingly led to a string of overly aggressive prosecutions in recent years, so newly sworn-in leaders of the U.S. Department of Justice should consider creating reporting channels to stop unwise prosecutions before they snowball, says Jonathan Porter at Husch Blackwell.

  • Opinion

    Judge Should Not Have Been Reprimanded For Alito Essay

    Author Photo

    Senior U.S. District Judge Michael Ponsor's New York Times essay critiquing Supreme Court Justice Samuel Alito for potential ethical violations absolutely cannot be construed as conduct prejudicial to the administration of the business of the courts, says Ashley London at the Thomas R. Kline School of Law of Duquesne University.

  • A Look At Drug Price Negotiation Program's Ongoing Impact

    Author Photo

    More than two years after the passage of the Inflation Reduction Act and the rapid implementation of the drug price negotiation program, attorneys at Ropes & Gray discuss how the IRA has influenced licensing strategies, and how maximum fair prices under the law have economically affected certain drugs.

  • Opinion

    Congress Must Consider Accurate Data About Patent Thickets

    Author Photo

    If Congress revisits a controversial bill this year aimed at limiting the number of patents pharmaceutical manufacturers could assert, it must make sure to act based on accurate reports — such as a recent U.S. Patent and Trademark Office study that found no evidence of patent thicketing, says David Kappos at the Council for Innovation Promotion.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!